Recent advances in the treatment of psoriasis : Advances in clinical researchGUZZO, C.Dermatologic clinics. 1997, Vol 15, Num 1, issn 0733-8635, 8,59-68 [11 p.]Article

Infliximab improves health related quality of life an physical function in patients with psoriatic arthritisKAVANAUGH, A; ANTONI, C; KRUEGER, G. G et al.Annals of the rheumatic diseases. 2006, Vol 65, Num 4, pp 471-477, issn 0003-4967, 7 p.Article

Persistent light reactivity from systemic quinineGUZZO, C; KAIDBEY, K.Photodermatology photoimmunology & photomedicine. 1990, Vol 7, Num 4, pp 166-168Article

Unusual abdominal location of a dermal cylindromaGUZZO, C; JOHNSON, B.Cutis (New York, NY). 1995, Vol 56, Num 4, pp 239-240, issn 0011-4162Article

Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment : Results from the induction and maintenance psoriatic arthritis clinical trial 2VAN DER HEIJDE, D; KAVANAUGH, A; BIRBARA, C et al.Arthritis and rheumatism. 2007, Vol 56, Num 8, pp 2698-2707, issn 0004-3591, 10 p.Article

Alterations in renal function in psoriasis patients treated with cyclosporine, 5 mg/kg/dayMARGOLIS, D. J; GUZZO, C; JOHNSON, J et al.Journal of the American Academy of Dermatology. 1992, Vol 26, Num 2, pp 195-197, issn 0190-9622, 1Article

Cockarde nevus: a case report and review of the literatureGUZZO, C; JOHNSON, B; HONIG, P et al.Pediatric dermatology. 1988, Vol 5, Num 4, pp 250-253, issn 0736-8046Article

Cyclosporine as maintenance therapy in patients with severe psoriasisSHUPACK, J; ABEL, E; MCDONALD, C et al.Journal of the American Academy of Dermatology. 1997, Vol 36, Num 3, pp 423-432, issn 0190-9622, 1Article

Treatment of psoriasis with piritrexim, a lipid-soluble folate antagonistGUZZO, C; BENIK, K; LAZARUS, G et al.Archives of dermatology (1960). 1991, Vol 127, Num 4, pp 511-514, issn 0003-987X, 4 p.Article

Urticaria pigmentosa : systemic evaluation and successful treatment with tropical steroidsGUZZO, C; LAVKER, R; ROBERTS, L. J et al.Archives of dermatology (1960). 1991, Vol 127, Num 2, pp 191-196, issn 0003-987X, 6 p.Article

An Eco R1 polymorphism of a human platelet factor 4 (PF4) geneGUZZO, C; WEINER, M; RAPPAPORT, E et al.Nucleic acids research. 1987, Vol 15, Num 1, issn 0305-1048, 380Article

Cardiovascular Disease and Risk Factors among Psoriasis Patients in Two US Healthcare Databases, 2001-2002KIMBALL, A. B; ROBINSON, D; WU, Y et al.Dermatology (Basel). 2008, Vol 217, Num 1, pp 27-37, issn 1018-8665, 11 p.Article

Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasisFELDMAN, S. R; GOTTLIEB, A. B; BALA, M et al.British journal of dermatology (1951). 2008, Vol 159, Num 3, pp 704-710, issn 0007-0963, 7 p.Article

Topical auranofin ointment for the treatment of plaque psoriasisHELM, K. F; MARKS, J. G; LEYDEN, J. J et al.Journal of the American Academy of Dermatology. 1995, Vol 33, Num 3, pp 517-519, issn 0190-9622Article

Efficacy and pharmacokinetics of two formulations of cyclosporine A in patients with psoriasisELDER, C. A; MOORE, M; KARARA, A. H et al.Journal of clinical pharmacology. 1995, Vol 35, Num 9, pp 865-875, issn 0091-2700Conference Paper

Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studiesREICH, K; LANGLEY, R. G; LEBWOHL, M et al.British journal of dermatology (1951). 2011, Vol 164, Num 4, pp 862-872, issn 0007-0963, 11 p.Article

Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment : results from the IMPACT 2 trialKAVANAUGH, A; KRUEGER, G. G; BIRBARA, C et al.Annals of the rheumatic diseases. 2007, Vol 66, Num 4, pp 498-505, issn 0003-4967, 8 p.Article

Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis : a double-blind placebo-controlled trialFELDMAN, S. R; GORDON, K. B; BALA, M et al.British journal of dermatology (1951). 2005, Vol 152, Num 5, pp 954-960, issn 0007-0963, 7 p.Article

Increased formation of thromboxane in vivo in humans with mastocytosisMORROW, J. D; OATES, J. A; ROBERTS, L. J et al.Journal of investigative dermatology. 1999, Vol 113, Num 1, pp 93-97, issn 0022-202XArticle

Recurrent recall of sunburn bu methotrexateGUZZO, C; KAIDBY, K.Photodermatology photoimmunology & photomedicine. 1995, Vol 11, Num 2, pp 55-56, issn 0905-4383Conference Paper

Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 yearsKIMBALL, A. B; GORDON, K. B; FAKHARZADEH, S et al.British journal of dermatology (1951). 2012, Vol 166, Num 4, pp 861-872, issn 0007-0963, 12 p.Article

Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis : a randomized controlled trialREICH, K; NESTLE, F. O; GRIFFITHS, C. E. M et al.British journal of dermatology (1951). 2006, Vol 154, Num 6, pp 1161-1168, issn 0007-0963, 8 p.Article

Failure to demonstrate therapeutic tachyphylaxis to topically applied steroids in patients with psoriasisMILLER, J. J; ROLING, D; MARGOLIS, D et al.Journal of the American Academy of Dermatology. 1999, Vol 41, Num 4, pp 546-549, issn 0190-9622Article

The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasisKRUEGER, G. G; DRAKE, L. A; ELIAS, P. M et al.Archives of dermatology (1960). 1998, Vol 134, Num 1, pp 57-60, issn 0003-987XArticle

Topical calcipotriene has not short-term effect on calcium and bone metabolism of patients with psoriasisGUZZO, C; LAZARUS, G; GOFFE, B. S et al.Journal of the American Academy of Dermatology. 1996, Vol 34, Num 3, pp 429-433, issn 0190-9622Article